Monday, October 27, 2025
- 2:00PM-2:15PM
-
Abstract Number: 1666
Treatment with Rilzabrutinib was associated with Rapid and Sustained Reduction in Disease Activity in Patients with IgG4-RD Previously Treated or Naïve to B cell Depletion
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II: Models and Mechanisms (1662–1667)- 2:15PM-2:30PM
-
Abstract Number: 1655
Aberrant Noncoding RNAs Are Enriched in Extracellular Vesicles and Implicated in Interferon Activation
Abstracts: Cytokines & Cell Trafficking (1650–1655)- 2:15PM-2:30PM
-
Abstract Number: 1661
Artificial Intelligence applied to Patient Reported Outcomes and Passive Physiologic Sensor Data can Accurately Classify Low Disease Activity in Rheumatoid Arthritis Patients
Abstracts: Health Services Research (1656–1661)- 2:15PM-2:30PM
-
Abstract Number: 1679
Does First-Line b- or tsDMARDs Choice Influence Progression to Difficult-to-Treat Rhumatoid arthritis? Insights from our longitudinal RA UCLouvain Brussels cohort
Abstracts: Rheumatoid Arthritis – Treatment I: Preventative and Novel Treatments (1674–1679)- 2:15PM-2:30PM
-
Abstract Number: 1673
Is Transient Synovitis of the Hip preclinical Juvenile SpA ? A follow-up study
Abstracts: Pediatric Rheumatology – Clinical I (1668–1673)- 2:15PM-2:30PM
-
Abstract Number: 1667
Recurrent or Incident Pericarditis With Concurrent Autoimmune Disease: Stable Control With Rilonacept Interleukin-1 Pathway Inhibition
Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II: Models and Mechanisms (1662–1667)- 2:15PM-2:30PM
-
Abstract Number: 1685
The Sjögren’s Tool for Assessing Response (STAR) demonstrates its ability to accurately detect treatment efficacy in 11 recent RCTs in Sjögren’s disease
Abstracts: Sjögren’s Disease – Basic & Clinical Science (1680–1685)- 3:00PM-3:15PM
-
Abstract Number: 1710
Defining sonographic enthesitis in psoriatic arthritis: Developing a data- and expert-driven definition for inflammatory enthesitis at the single enthesis level
Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes I: Advances in Psoriatic Disease (1710–1715)- 3:00PM-3:15PM
-
Abstract Number: 1704
Relationships between Neighborhood Disadvantage, Cumulative Social Disadvantage, and JIA Outcomes: A CARRA Registry Study
Abstracts: Healthcare Disparities in Rheumatology (1704–1709)- 3:00PM-3:15PM
-
Abstract Number: 1692
Rheumatoid factor is associated with increased gut permeability and migration of B cells to the joint via CXCR3 in rheumatoid arthritis
Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease (1691–1697)- 3:00PM-3:15PM
-
Abstract Number: 1716
The frequency and impact of cardiovascular disease in systemic lupus erythematosus: a Nationwide, matched case-control study.
Abstracts: Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes II: Morbidity & Mortality (1716–1721)- 3:00PM-3:15PM
-
Abstract Number: 1686
The Prevalence of Depressive Symptoms and Persistent Depression among Older Adults with Systemic Lupus Erythematosus (SLE)
Abstracts: ARP I: Multidimensional Influences on Health in SLE (1686–1691)- 3:00PM-3:15PM
-
Abstract Number: 1698
X Chromosome DNA Methylation Changes Suggest Epigenetic Contributions to Immune Dysregulation in Male Lupus